David Beidler
Pfizer (United States)(US)
Publications by Year
Research Areas
Cannabis and Cannabinoid Research, Cancer therapeutics and mechanisms, Hemoglobinopathies and Related Disorders, Cell death mechanisms and regulation, Iron Metabolism and Disorders
Most-Cited Works
- → Discovery and Characterization of a Highly Selective FAAH Inhibitor that Reduces Inflammatory Pain(2009)440 cited
- → The Baculovirus p35 Protein Inhibits Fas- and Tumor Necrosis Factor-induced Apoptosis(1995)367 cited
- → Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain(2011)229 cited
- → Discovery of PF-04457845: A Highly Potent, Orally Bioavailable, and Selective Urea FAAH Inhibitor(2010)196 cited
- → CrmA-inhibitable Cleavage of the 70-kDa Protein Component of the U1 Small Nuclear Ribonucleoprotein during Fas- and Tumor Necrosis Factor-induced Apoptosis(1995)180 cited
- → Spk1, a New Kinase from Saccharomyces cerevisiae , Phosphorylates Proteins on Serine, Threonine, and Tyrosine(1991)128 cited
- → Proinflammatory cytokines, IL-1β and TNF-α, induce expression of interleukin-34 mRNA via JNK- and p44/42 MAPK-NF-κB pathway but not p38 pathway in osteoblasts(2010)101 cited
- → Camptothecin induction of a time- and concentration-dependent decrease of topoisomerase I and its implication in camptothecin activity.(1995)99 cited
- → Overexpression of Bcl-xL Promotes Chemotherapy Resistance of Mammary Tumors in a Syngeneic Mouse Model(1999)90 cited
- → Macrophage-colony stimulating factor and interleukin-34 induce chemokines in human whole blood(2010)76 cited